Benjamin Ebert, MD, PhD

Dr. Benjamin Ebert is a Professor of Medicine at Harvard Medical School, an Institute Member of the Broad Institute, and Leader of the Leukemia Program for the Dana-Farber/Harvard Cancer Center.  He received a bachelor's degree from Williams College, a doctorate from Oxford University on a Rhodes Scholarship, and an M.D. from Harvard Medical School. He completed a residency in internal medicine at Massachusetts General Hospital and a fellowship in hematology/oncology at the Dana-Farber Cancer Institute.  

Dr. Ebert is President-elect of the American Society for Clinical Investigation and an elected member of the Association of American Physicians.  His awards include a Burroughs Wellcome Career Award, a Leukemia and Lymphoma Society Scholar Award, the Till and McCollough Award from the International Society of Experimental Hematopoiesis, and mentoring and teaching awards from Harvard Medical School.  He serves on the medical or scientific advisory boards of the Evans Foundation, the MDS Foundation, and the Aplastic Anemia and MDS Foundation.

The Ebert laboratory has a long-standing interest in the genetic lesions that drive myeloid malignancies, with a particular focus on myelodysplastic syndromes and clonal hematopoiesis, and the clinical and biological consequences of specific mutations.  Recent work includes elucidation of the mechanism of action of lenalidomide and related compounds.